$7.50
-0.12-1.57%
At close: -
$7.50
0.000.00%
After Hours: May 23, 4:00 PM EDT
Comments
Loading...
Entrada Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TRDA | Benzinga
Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$-0.420
Quarterly Revenue
$20.56M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$172.22M
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics | $1.55 | — | — | — | $94.69M | — | — | — | 08/12/2025 | Get Alert |
| TRDA | Entrada Therapeutics | $0.68 | -$0.72 | -$0.42 | 41.67% | $59.12M | $11.95M | $20.56M | 72.03% | 05/08/2025 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.29 | -$0.66 | $0.03 | 104.55% | $41.85M | $12.92M | $37.40M | 189.46% | 02/27/2025 | Get Alert |
| TRDA | Entrada Therapeutics | $1.02 | -$0.73 | -$0.35 | 52.05% | $43.73M | $12.32M | $19.57M | 58.85% | 11/05/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.78 | $0.14 | $1.55 | 1007.14% | $18.17M | $46.07M | $94.69M | 105.54% | 08/13/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.21 | -$0.59 | $0.68 | 215.25% | $25.26M | $14.98M | $59.12M | 294.66% | 05/07/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.79 | -$0.17 | -$0.29 | -70.59% | $0.00 | $23.69M | $41.85M | 76.65% | 03/13/2024 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.80 | -$0.74 | $1.02 | 237.84% | $0.00 | $9.60M | $43.73M | 355.57% | 11/07/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.74 | — | -$0.78 | — | $0.00 | — | $18.17M | — | 08/08/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.69 | — | -$0.21 | — | $0.00 | — | $25.26M | — | 05/10/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$0.89 | -$0.83 | -$0.79 | 4.82% | $0.00 | — | $0.00 | — | 03/06/2023 | Get Alert |
| TRDA | Entrada Therapeutics | -$9.78 | -$0.76 | -$0.80 | -5.26% | $0.00 | — | $0.00 | — | 11/07/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$7.56 | — | -$0.74 | — | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$6.67 | — | -$0.69 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$7.47 | — | -$0.89 | — | $0.00 | — | $0.00 | — | 03/15/2022 | Get Alert |
| TRDA | Entrada Therapeutics | -$6.13 | — | -$9.78 | — | $0.00 | — | $0.00 | — | 12/09/2021 | Get Alert |
Entrada Therapeutics (TRDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.42 | $-0.72 | 41.7 % |
| Q4 | 2025-02-27 | $0.03 | $-0.66 | 104.6 % |
| Q3 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
| Q2 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
Entrada Therapeutics (TRDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $20.56M | $11.95M | 72.0 % |
| Q4 | 2025-02-27 | $37.40M | $12.92M | 189.5 % |
| Q3 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
| Q2 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
FAQ
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics (TRDA) is scheduled to report earnings on August 12, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Entrada Therapeutics (NASDAQ:TRDA)?
The Actual EPS was $-0.42, which beat the estimate of $-0.72.
What were Entrada Therapeutics’s (NASDAQ:TRDA) revenues?
The Actual Revenue was $20.6M, which beat the estimate of $11.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
